TP53 and cancer: The correlation between the SYK gene mRNA expression and different clinicopathological parameters in “TCGA” COAD tissues demonstrated that the SYK gene was significantly upregulated based on other variables, such as sample types, individual cancer stages, race, gender, weight, age, histological subtypes, nodal metastasis status, and TP53 mutation status.